Insider Trading & Ownership - Eterna Therapeutics Inc. (ERNA)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Eterna Therapeutics Inc.
Goto 0, 1, 2, 3, Next
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2024-10-29
Purchase		2024-11-05
12:42 pm		Eterna Therapeutics Inc.ERNACherington Charles
10% Owner		13,252,112$0$029,823,881
(Direct)		View
2022-12-02
Purchase		2022-12-06
9:02 pm		Eterna Therapeutics Inc.ERNACherington Charles
Director
10% Owner		261,756$3.28$858,5601,079,977
(Direct)		View
2022-12-02
Purchase		2022-12-06
6:52 pm		Eterna Therapeutics Inc.ERNASinger Nicholas Jason
Director		283,286$3.28$929,178832,786
(Indirect)		View
2022-12-02
Purchase		2022-12-05
6:05 pm		Eterna Therapeutics Inc.ERNAHALPERN JOHN D
10% Owner		335,920$3.28$1,101,8181,123,006
(Indirect
Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2024-10-29
Conversion		2024-11-05
12:42 pm		N/A
2025-09-24		Eterna Therapeutics Inc.ERNACherington Charles
10% Owner		1,368,626$029,823,881
(Direct)		View
2024-10-29
Conversion		2024-11-05
12:42 pm		N/A
N/A		Eterna Therapeutics Inc.ERNACherington Charles
10% Owner		2,819,546$0.529,823,881
(Direct)		View
2024-06-21
Tax Withholding		2024-06-25
4:32 pm		N/A
N/A		Eterna Therapeutics Inc.ERNAGurrola Sandra M
Sr. VP of Finance		180$1.941,622
(Direct)		View
2024-06-21
Exercise		2024-06-25
4:32 pm		N/A
N/A		Eterna Therapeutics Inc.ERNAGurrola Sandra M
Sr. VP of Finance		437$01,622
(Direct)		View
2024-04-26
Option Award		2024-04-29
4:31 pm		N/A
2034-04-26		Eterna Therapeutics Inc.ERNACicala Peter
Director		88,946$088,946
(Direct)		View
2024-04-26
Option Award		2024-04-29
4:30 pm		N/A
2034-04-26		Eterna Therapeutics Inc.ERNAGurrola Sandra M
Sr. VP of Finance		80,000$080,000
(Direct)		View
2024-04-26
Option Award		2024-04-29
4:30 pm		N/A
2034-04-26		Eterna Therapeutics Inc.ERNABristol James Arthur
Director		124,525$0124,525
(Direct)		View
2024-01-01
Option Award		2024-01-03
5:02 pm		N/A
2034-01-01		Eterna Therapeutics Inc.ERNALuther Sanjeev
President and CEO		1,685,218$01,685,218
(Direct)		View
2024-01-01
Option Award		2024-01-03
5:01 pm		N/A
2034-01-01		Eterna Therapeutics Inc.ERNAClarke Dorothy J
General Counsel
Director		168,521$0168,521
(Direct)		View
2023-12-14
Expired		2023-12-20
10:05 am		2023-07-14
2028-07-14		Eterna Therapeutics Inc.ERNACherington Charles
10% Owner		2,831,204$08,957,180
(Direct)		View
2023-12-14
Option Award		2023-12-18
9:38 pm		2023-06-02
2028-06-02		Eterna Therapeutics Inc.ERNAFreebird Partners LP
Freebird Investments LLC
HUFF CURTIS W
10% Owner		949,402$05,622,833
(Direct)		View
2023-12-14
Disposition		2023-12-18
9:38 pm		2023-06-02
2028-06-02		Eterna Therapeutics Inc.ERNAFreebird Partners LP
Freebird Investments LLC
HUFF CURTIS W
10% Owner		949,402$05,622,833
(Direct)		View
2023-06-21
Tax Withholding		2023-06-23
8:30 pm		N/A
N/A		Eterna Therapeutics Inc.ERNAGurrola Sandra M
Vice President of Finance		179$2.481,802
(Direct)		View
2023-06-21
Exercise		2023-06-23
8:30 pm		N/A
N/A		Eterna Therapeutics Inc.ERNAGurrola Sandra M
Vice President of Finance		438$01,802
(Direct)		View

Ownership		2023-04-04
5:03 pm		N/A
N/A		Eterna Therapeutics Inc.ERNAFreebird Partners LP
Freebird Investments LLC
HUFF CURTIS W
10% Owner		0$0697,510
(Direct)		View

Ownership		2023-03-06
4:01 pm		N/A
N/A		Eterna Therapeutics Inc.ERNADENNY GEORGE P III
10% Owner		0$0460,413
(Indirect)		View
2023-01-12
Option Award		2023-01-13
7:30 pm		N/A
2033-01-12		Eterna Therapeutics Inc.ERNAAngel Matthew
President and CEO		132,003$0132,003
(Direct)		View
2022-09-20
Exercise		2022-09-21
7:00 pm		N/A
N/A		Brooklyn ImmunoTherapeutics Inc.BTXSidhu Roger
Chief Medical Officer		20,163$080,650
(Direct)		View
2022-08-01
Option Award		2022-08-03
8:01 pm		N/A
2032-08-01		Brooklyn ImmunoTherapeutics Inc.BTXAngel Matthew
Interim President and CEO		2,487,003$02,487,003
(Direct)		View
2022-08-01
Option Award		2022-08-03
8:01 pm		N/A
2032-08-01		Brooklyn ImmunoTherapeutics Inc.BTXCherington Charles
Director		380,900$0380,900
(Direct)		View
2022-08-01
Option Award		2022-08-03
8:01 pm		N/A
2032-08-01		Brooklyn ImmunoTherapeutics Inc.BTXFiore Gregory
Director		260,900$0260,900
(Direct)		View
2022-08-01
Option Award		2022-08-03
8:01 pm		N/A
2032-08-01		Brooklyn ImmunoTherapeutics Inc.BTXWexler William A.
Director		317,900$0317,900
(Direct)		View
2022-08-01
Option Award		2022-08-03
8:01 pm		N/A
2032-08-01		Brooklyn ImmunoTherapeutics Inc.BTXSinger Nicholas Jason
Director		311,900$0311,900
(Direct)		View
2022-06-28
Tax Withholding		2022-06-29
8:01 pm		N/A
N/A		Brooklyn ImmunoTherapeutics Inc.BTXDAmour Kevin
Chief Scientific Officer		6,077$0.553464,213
(Direct)		View
2022-06-28
Exercise		2022-06-29
8:01 pm		N/A
N/A		Brooklyn ImmunoTherapeutics Inc.BTXDAmour Kevin
Chief Scientific Officer		17,573$064,213
(Direct)		View
2022-06-21
Tax Withholding		2022-06-23
8:31 pm		N/A
N/A		Brooklyn ImmunoTherapeutics Inc.BTXGurrola Sandra M
Vice President of Finance		3,586$0.476539,617
(Direct)		View
2022-06-21
Exercise		2022-06-23
8:31 pm		N/A
N/A		Brooklyn ImmunoTherapeutics Inc.BTXGurrola Sandra M
Vice President of Finance		8,750$039,617
(Direct)		View

Ownership		2022-06-07
9:08 pm		N/A
N/A		Brooklyn ImmunoTherapeutics Inc.BTXSinger Nicholas Jason
Director		0$02,095,000
(Indirect)		View
2022-06-03
Option Award		2022-06-06
5:01 pm		N/A
2032-06-03		Brooklyn ImmunoTherapeutics Inc.BTXJackson Andrew C.
Chief Financial Officer		664,800$0664,800
(Direct)		View
Goto 0, 1, 2, 3, Next